In the last 12 years, the number of infants under six months of age globally who are exclusively breastfed has increased by more than 10%.
ArsenalBio secures $325m to develop cell therapy programmes
ArsenalBio’s pipeline comprises potential therapies being developed for treating solid tumours. Credit: shisu_ka/Shutterstock. ArsenalBio has closed an oversubscribed Series C financing round, securing $325m to
September 5, 2024